Drug approvals in Europe| EMA drug approvals | 2023 |European Commission News| iPharmaCenter




CHMP Positive Opinions | EMA Drug Approvals | European Commission | 2023 | iPharmaCenter


Medicines and Healthcare products Regulatory Agency | News | 2023 Approvals | iPharmaCenter


2022 | CHMP Positive Opinions | EMA Drug Approvals | European Commission | Pharma | News


Drug approvals in Europe| EMA drug approvals in 2022 |European Commission News| iPharmaCenter


France healthcare News | HAS Sante | COVID 19 | Drug approvals | iPharmaCenter


COVID19 drug updates | FDA EMA approved COVID19 drugs
Opdualag was approved for unresectable/metastatic melanoma | LAG-3 inhibitors | Mode of action


European Commission approved Scemblix for chronic myeloid leukemia | iPharmaCenter


Roche’s Polivy was approved as first-line therapy for patients with DLBCL.


Germany HTA News | IQWIG and G-BA assessment news | Germany Pharma News


European Commission approved Roche's and Celltrion's monoclonal antibodies for COVID19


European Commission approved Benlysta for active lupus nephritis


France COVID-19 Updates | COVID-19 News in Europe


GSK’s Jemperli received approval in Europe and the US for endometrial cancer


England patients to benefit from Phesgo, 5-minute breast cancer treatment from Roche


CHMP Opinions | EMA drug approvals


Novartis and BeiGene collaboration strengthens the Swiss drugmaker's oncology portfolio
Biogen initiated Phase 4 trial to determine the efficacy of Spinraza in Zolgensma treated patients
Kite’s CAR-Tcell therapy received approval in Europe for relapsed or refractory mantle cell lymphoma


European Commission to purchase 200 million doses of Johnson and Johnson's COVID 19 vaccine

HAS says Gilead's Veklury 'does not improve benefit' for COVID19 patients; EMA to review safety


ESMO 2020


Oxford vaccine trials were paused because of safety concerns; AZ said it’s ‘routine’


European Commission approved GSK’s Blenrep for relapsed and refractory multiple myeloma
JULY 2020 CHMP POSITIVE OPINION
European Commission approved Lynparza for metastatic pancreatic cancer
Gilead’s Veklury received conditional marketing authorization from the European Commission
European Commission approved Janssen's Ebola vaccine
GSK and Clover Biopharmaceuticals begins COVID-19 vaccine Phase 1 clinical trial
Governments and other organizations raised US$ 8.8 billion at Global Vaccine Summit
#EULAR2020
Sanofi’s Sarclisa approved in Europe for relapsed and refractory multiple myeloma
Gilead announced the positive Phase 3 trial of remdesivir in COVID-19 patients
European Commission approved Zolgensma, activates “Day one” access program
HAS gave favorable opinion for reimbursing Darzalex for treating multiple myeloma naïve patients
EMA allowed compassionate use of remdesivir to patients who were not on mechanical ventilation
PFIZER AND BIONTECH STARTS THE CLINICAL TRIALS OF COVID-19 VACCINE
Novo Nordisk’s Rybelsus approved by European Union


NICE recommendation to manage symptoms of COVID-19


EMA approved GSK’s Trelegy Ellipta for asthma
EMA approved Mayzent (siponimod) for secondary progressive multiple sclerosis


European Commission approved AbbVie's Rinvoq (upadacitinib) for adults with moderate to severe RA
CHMP gave positive opinions for Beovu and Recarbrio